Search Prime Grants

P30GM138395

Project Grant

Overview

Grant Description
The Biophysics Collaborative Access Team - The mission of the Biophysics Collaborative Access Team (BioCAT) is to provide user access to a state-of-the-art synchrotron beamline (18ID) for diffraction and scattering of non-crystalline biological materials at the Advanced Photon Source, Argonne National Lab.

Continued evolution of the beamline since first light in 1997 has resulted in a unique in the USA fiber diffraction program, and a world-class bio-SAXS program with unique capabilities both in the equilibrium and time-resolved realms.

The use of size exclusion chromatography in line with the SAXS camera has ensured unprecedentedly high data quality even with biochemically challenging samples otherwise thought to be intractable for SAXS.

The recent incorporation of MALS and DLS in line with SEC allows additional biophysical characterization that can be invaluable in interpreting SAXS data from difficult systems.

Our new coflow sheath flow sample cell has revolutionized SAXS data acquisition by preventing radiation damage, enhancing efficiency accompanied by significant increases in signal to noise.

BioCAT maintains specialized apparatuses for combined time-resolved X-ray diffraction and physiological studies of cardiac and skeletal muscle.

These studies have extended in scope from basic biophysical problems to address new disease models including cardiomyopathies.

A traditional strength is fiber diffraction of general fibrous protein systems that has recently expanded into scanning diffraction imaging of fibrous protein structures in complex tissue samples.

A major strength of the resource is the experienced and dedicated scientific staff who assist users seven days a week in data acquisition, processing, analysis, and interpretation.

BioCAT is directed by Dr. Thomas Irving, who has more than 20 years of experience overseeing synchrotron facilities for non-crystalline diffraction and scattering.

Dr. Jesse Hopkins oversaw installation of the new coflow SAXS sample cell, established new user-friendly GUI-based data acquisition interfaces, and provided advanced tools to interpret SEC-SAXS data.

Dr. Hopkins develops and maintains the BioXTAS RAW SAXS data processing and analysis software package and will extend it to allow increased automation to optimize productivity while minimizing on-site effort for users.

Dr. Srinivas Chakravarthy, BioCAT's resident biochemist, coordinates the SAXS user program, assists users with conducting experiments on site, and also maintains the biochemical infrastructure.

Dr. Weikang Ma is an expert in fiber diffraction of muscle and is responsible for providing comprehensive support to all our fiber diffraction users.

All four of these individuals are involved in training and dissemination activities, including scientific publications, presentations at conferences, organization of BioCAT workshops, and participating in community-organized workshops.

BioCAT has an updated website with a comprehensive set of instructions for all aspects of the resource that are sufficient for a user to plan and execute successful experiments at the beamline.

Together, the SAXS and fiber diffraction user programs host 70-90 user groups per year and consistently produce 30-40 publications per year.
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Place of Performance
Illinois United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the total obligations have increased 199% from $3,753,029 to $11,217,594.
Illinois Institute Of Technology was awarded BIOCAT: Biophysics Access Team for Synchrotron Beamline Project Grant P30GM138395 worth $11,217,594 from the National Institute of General Medical Sciences in February 2021 with work to be completed primarily in Illinois United States. The grant has a duration of 4 years 10 months and was awarded through assistance program 93.859 Biomedical Research and Research Training. The Project Grant was awarded through grant opportunity Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
2/1/21
Start Date
12/31/25
End Date
95.0% Complete

Funding Split
$11.2M
Federal Obligation
$0.0
Non-Federal Obligation
$11.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to P30GM138395

Transaction History

Modifications to P30GM138395

Additional Detail

Award ID FAIN
P30GM138395
SAI Number
P30GM138395-364462416
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
E2NDENMDUEG8
Awardee CAGE
8B088
Performance District
IL-90
Senators
Richard Durbin
Tammy Duckworth

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) Health research and training Grants, subsidies, and contributions (41.0) $3,044,225 100%
Modified: 9/24/25